Key Highlights
- Eli Lilly and Nimbus Therapeutics have formed a partnership.
- The collaboration focuses on an oral treatment for obesity.
- The agreement includes exclusive licensing rights.
- The initiative targets other metabolic diseases as well.
Eli Lilly, Nimbus Partner to Develop, License Oral Obesity Treatment
Eli Lilly and Nimbus Therapeutics have announced a multiyear collaboration to develop and license an oral treatment aimed at addressing obesity and other metabolic diseases.
Loading ad...
Loading ad...
Sources
This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.
Related Stories
Air Hostess Dies By Suicide In Thane, Case Filed Against Ex-Boyfriend
AI
January 14, 2026
Pongal Shining Symbol Of Richness Of Tamil Traditions: PM Modi
AI
January 14, 2026
Rape case: Police to examine Kerala MLA Rahul Mamkootathil’s phones for evidence after he declines to share passwords
AI
January 14, 2026